CIK: 0001278387 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 14, 2017
Total Value ($000): $589,876 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MNST | MONSTER BEVERAGE CORP NEW | 4,797,408 | $212,717 | 36.1% | $22.71 | +0.8% | COM | 61174X109 |
| STAA | STAAR SURGICAL CO | 10,855,179 | $117,779 | 20.0% | $8.21 | +23.9% | COM PAR $0.01 | 852312305 |
| — | BIOTIME INC | 24,897,032 | $89,878 | 15.2% | $3.49 | — | COM | 09066L105 |
| — | CYNOSURE INC | 1,338,827 | $61,051 | 10.3% | $32.70 | — | CL A | 232577205 |
| IWM | ISHARES TR | 420,000 | $56,637 | 9.6% | $109.78 | — | RUSSELL 2000 ETF | 464287655 |
| — | ONCOCYTE CORPORATION | 2,631,680 | $18,553 | 3.1% | $5.54 | — | COM | 68235C107 |
| — | ASTERIAS BIOTHERAPEUTICS INC | 3,699,848 | $17,019 | 2.9% | $3.75 | — | COM SER A | 04624N107 |
| — | MALLINCKRODT PUB LTD CO | 322,411 | $16,063 | 2.7% | $90.15 | — | SHS | G5785G107 |
| — | ASTERIAS BIOTHERAPEUTICS INC | 328,205 | $179 | 0.0% | $0.21 | — | *W EXP 02/15/201 | 04624N115 |